Price
No data yet.
Social Signal Score
Analyst Ratings
46 analystsRevenue
$20.23B+96.98%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Samuel N. Hazen
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 320,000
- Beta
- 1.11
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.59
Financials
Revenue
$20.23B+97.0%Net Income
$1.70B+174.9%EBITDA
$4.01B+106.2%Free Cash Flow
$1.10B+123.5%EPS (diluted)
$7.62+379.2%Shares Outstanding (diluted)
222.83M-42.8%Operating Expenses
$8.29BCash & Debt
$1.01BReturn of Capital
$2.23BRevenue by Segment (annual)
$73.14BDividend per Share
$0.78Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $75.60B | $6.78B | $28.62 |
| 2024 | $70.60B | $5.76B | $22.27 |
| 2023 | $64.97B | $5.24B | $19.24 |
| 2022 | $60.23B | $5.64B | $19.44 |
| 2021 | $58.75B | $6.96B | $21.51 |
| 2020 | $51.53B | $3.75B | $11.08 |
| 2019 | $51.34B | $3.50B | $10.27 |
| 2018 | $46.68B | $3.79B | $11.04 |
| 2017 | $43.61B | $2.22B | $6.33 |
| 2016 | $41.49B | $2.89B | $7.80 |
| 2015 | $39.68B | $2.13B | $5.34 |
| 2014 | $36.92B | $1.88B | $4.46 |
| 2013 | $34.18B | $1.56B | $3.54 |
| 2012 | $33.01B | $1.60B | $3.62 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from HCA's reported EPS growth of 17.2% a year over 13 years.
- EPS in 5 years
- $65.02
- Implied price
- $1,040
- Return from $426.69
- 19.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $517.24 — today's price is already 17.5% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 14 | 16 | 18 | 20 |
|---|---|---|---|---|---|
| 7.2% | 3.2% | 6.4% | 9.3% | 11.9% | 14.3% |
| 12.2% | 8.0% | 11.4% | 14.4% | 17.1% | 19.6% |
| 17.2% | 12.8% | 16.4% | 19.5% | 22.4% | 25.0% |
| 22.2% | 17.6% | 21.3% | 24.6% | 27.6% | 30.3% |
| 27.2% | 22.5% | 26.3% | 29.7% | 32.8% | 35.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50+0.00%Social Signal Score
Mentions (17)
- Newsbusinesswire.com·5d ago·Neutral
HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2026 Earnings Call When: Tuesday, October 27, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If y…
View source ↗ - Newsbusinesswire.com·6d ago·Positive
HCA Healthcare Presents 2026 Awards of Distinction NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction, which include the Frist Humanitarian Award and the Excellence in Nursing Award, are the highest honors HCA Healthcare bestows on colleagues, nurses, physicians and volunteers, recognizin…
View source ↗ - Newszacks.com·7d ago·Negative
Can Shorter Hospital Stays Help HCA Handle More Patient Demand? HCA's rising admissions and shorter hospital stays could help it meet growing patient demand while using existing capacity more efficiently.
View source ↗ - Newszacks.com·11d ago·Neutral
Can HCA Sustain Earnings Growth Despite a Changing Service Mix? HCA Healthcare's healthy volume growth faces payer-mix pressure, but cost controls, network expansion and Medicaid payments may support earnings growth.
View source ↗ - Newsdefenseworld.net·12d ago·Neutral
Critical Survey: HCA Healthcare (NYSE:HCA) and Labcorp (NYSE:LH) HCA Healthcare (NYSE: HCA - Get Free Report) and Labcorp (NYSE: LH - Get Free Report) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership. Dividends HCA Healthcare pays an annual dividend of
View source ↗ - News (Marketaux)gurufocus.com·13d ago·Positive
HCA Looks 5.0% Undervalued on GF Value™ as Insider Selling Raises Caution On September 22, 2026, BMO Capital initi[+292 characters]
View source ↗ - News (RSS)seekingalpha·14d ago·Neutral
HCA Healthcare: Hold Until The Noise Clears
View source ↗ - News (RSS)yahoo·15d ago·Neutral
HCA Healthcare (HCA) Acquires a Healthcare College. Can Training Capacity Improve Staffing?
View source ↗ - Newsmarketbeat.com·18d ago·Neutral
HCA Healthcare Sees Solid Demand as Exchange Headwinds Pressure 2026 Outlook HCA Healthcare NYSE: HCA CFO Mike Marks said the hospital operator is navigating a changing policy environment in 2026 while continuing to see solid underlying demand for services outside of the health insurance exchanges.
View source ↗ - News (RSS)yahoo·19d ago·Negative
Alluvium Increases HCA Healthcare (HCA) Holdings After Its 17.5% Selloff
View source ↗ - Newsseekingalpha.com·20d ago·Positive
HCA Healthcare, Inc. (HCA) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript HCA Healthcare, Inc. (HCA) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
View source ↗ - News (RSS)investing·20d ago·Neutral
HCA Healthcare completes acquisition of health college CHCP
View source ↗ - Newsbusinesswire.com·21d ago·Neutral
MEDITECH Expanse EHR Live Across First Full U.S. Divisions of HCA Healthcare CANTON, Mass.--(BUSINESS WIRE)-- #Expanse--MEDITECH has completed implementation of its Expanse EHR platform across 34 hospitals in HCA Healthcare's Capital and North Florida divisions.
View source ↗ - Newsseekingalpha.com·26d ago·Positive
HCA Healthcare, Inc. (HCA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript HCA Healthcare, Inc. (HCA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - News (RSS)yahoo·34d ago·Neutral
HCA Healthcare (HCA) Navigates Patient Volume Challenges While Reporting Growth
View source ↗ - Newszacks.com·39d ago·Positive
Can Operational Resiliency Protect HCA's Long-Term Profitability? HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially supporting long-term profitability and EBITDA growth.
View source ↗ - Newsbusinesswire.com·46d ago·Neutral
HCA Healthcare, Inc. to Present at September Conferences NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: September 9, 2026, at 10:15am ET at the Wells Fargo Healthcare Conference September 15, 2026, at 1:50pm CT at the Jefferies Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the…
View source ↗
Earnings
Tue, Oct 27(in 3 weeks)
Consensus estimate $6.68 per share
Typical surprise +7.4% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Jul 24$7.59 vs $7.56beat
- Fri, Apr 24$7.15 vs $7.12beat
- Tue, Jan 27$8.01 vs $7.46beat
- Fri, Oct 24$6.96 vs $5.79beat
- Fri, Jul 25$6.84 vs $6.29beat
- Fri, Apr 25$6.45 vs $5.75beat
Estimates and results for HCA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by HCA officers and directors.
- Bought
- —
- Sold
- $29.3m
0 trades
12 trades
- Mcalevey Michael Rsold
- Wyatt Christopher F.sold
- Berres Jennifersold
- Berres Jennifersold
- Hazen Samuel Nsold
- Hazen Samuel Nsold
- Hazen Samuel Nsold
- Hazen Samuel Nsold
88 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Jared Moskowitzhouse · FL23 · disclosed Jul 27, 2026 (40d later)Buy$1,001 - $15,000
- Jared Moskowitzhouse · FL23 · disclosed Jul 27, 2026 (40d later)Buy$1,001 - $15,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (18d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (18d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (18d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (18d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (41d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (27d later)Buy$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Sep 12, 2025 (318d later)Buy$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Sep 12, 2025 (259d later)Sell$1,001 - $15,000
- Jared Moskowitzhouse · FL23 · disclosed Jun 30, 2025 (46d later)Buy$1,001 - $15,000
- Jared Moskowitzhouse · FL23 · disclosed Jun 30, 2025 (46d later)Buy$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed May 15, 2025 (38d later)Sell$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Mar 28, 2025 (31d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 11, 2024 (27d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2024 (26d later)Sell$1,001 - $15,000
- Josh S. Gottheimerhouse · NJ05 · disclosed Apr 7, 2024 (37d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (22d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (26d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.